On January 12, NP-G2-044 (Prilukae), a novel oral fascin inhibitor earned ODD for the treatment of pancreatic cancer. This designation covers the use of the agent as monotherapy and in combination ...
The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric ...
In what is shaping up to be a back-loaded month, the FDA is set to release a slew of regulatory decisions in February, ...
“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...
CTK recently completed FDA OTC registration and related compliance steps for three white-label suncare products: a sun lotion ...
The US Food and Drug Administration turned down a self-administered version of AstraZeneca Plc’s lupus medicine, but the UK drugmaker said it’s still working with regulators to advance the request.
It's not a drug, and it may also have some benefits to quell overeating—here's how tech is transforming mental health care.
Publication includes a systematic review of 24 studies describing off-label cutaneous application of statins in porokeratosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results